Nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes
This validated model estimates the 5-year risk of recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes. The c-index for the recurrence, distant metastasis and overall mortality model was 0.68, 0.70 and 0.70 respectively, and 0.70, 0.72 and 0.74 respectively in external validation.

The model is not appropriate for melanoma patients who did not undergo sentinel lymph node biopsy or those who have negative sentinel lymph nodes. 

Note: The underlying paper describing the development and validation of the model is currently being peer-reviewed and is expected to be available shortly. 
Research authors: D. Verver, A. Rekkas, C. Garbe, D. van Klaveren, A.C.J. van Akkooi, P. Rutkowski, B.W.E.M. Powell, C. Robert, A. Testori, B.L. van Leeuwen, A.A.M. van der Veldt, U. Keilholz, R. Stadler, A.M.M. Eggermont, C. Verhoef, U. Leiter, D.J. Grunhagen
Details Files & References
Composite
Model author
Version
1.7
Revision date
2020-05-22
Specialty
MeSH terms
No MeSH classifications added
Status
public
Share

Related files

No related files available

Supporting Publications

{{ resultSubheader }}

{{ model.survival.PITTitle }}

{{ model.survival.YNETitle }}

Results
Note
Notes are only visible in the result download and will not be saved by Evidencio

Composite model

Conditional information

Result interpretation

{{ file.classification }}

Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

Comments
Rating
Comment
Please enter a comment of rating
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote: